For at least one or more of the following outcomes—encephalitis, brain injury, or lack of brain function—we considered original studies and meta-analyses reporting adrenomedullin levels in patients with neurodegenerative conditions and viral infections. This evidence concerns the gene ADM and viral infectious disease.